Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,5.346974673634691e-47,29.390125351752367,3131.3699783828206,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.5825887673655556e-44,0,0,68
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.761284517764199e-17,7.262158834393597,276.8934119670796,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",6.668502110400541e-15,0,0,42
3,Nonalcoholic fatty liver disease WP4396,2.2145239428395174e-10,3.833973823447508,85.23235693237385,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'BBC3', 'LEPR', 'MLX', 'UQCRFS1', 'CYC1', 'XBP1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",3.565383547971623e-08,0,0,41
4,Oxidative phosphorylation WP623,2.961358734368348e-10,6.941236936782594,152.29214562500113,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFB4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'ATP5MC3', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",3.5758406717497805e-08,0,0,24
5,Mitochondrial CIV Assembly WP4922,2.1991313624413953e-08,9.212148736871985,162.43430237070382,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",2.1243608961183876e-06,0,0,16
6,Cholesterol Biosynthesis Pathway WP197,9.379748198483538e-07,14.915503306392358,207.02036552246926,"['IDI1', 'SQLE', 'HMGCS1', 'CYP51A1', 'MSMO1', 'MVD', 'HMGCR', 'DHCR7', 'LSS', 'FDFT1']",7.550697299779248e-05,0,0,10
7,Mitochondrial complex I assembly model OXPHOS system WP4324,6.226836759815665e-06,4.344753594163508,52.079006334273565,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.0004296517364272809,0,0,18
8,"GPCRs, Class A Rhodopsin-like WP455",8.657104266078509e-06,4.208564301552107,49.05978231988418,"['GPR27', 'OPRD1', 'P2RY12', 'PTGFR', 'GPR12', 'HTR1F', 'P2RY14', 'CHRM5', 'F2R', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR4', 'MCHR1', 'HCRTR2', 'HRH1', 'HTR7', 'MC1R']",0.00052267267006449,0,0,18
9,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,5.391328353414099e-05,4.149459193706981,40.7814395834843,"['IDI1', 'HMGCS1', 'CYP51A1', 'MSMO1', 'DHCR24', 'HMGCR', 'LSS', 'TM7SF2', 'SQLE', 'EBP', 'SCD', 'ACOT2', 'MVD', 'DHCR7', 'FDFT1']",0.0028933462163322327,0,0,15
10,Mitochondrial complex III assembly WP4921,0.00011674421636949913,8.50896132480872,77.05311371312534,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.005638745650646808,0,0,8
11,Selenium Micronutrient Network WP15,0.0008183263068075311,3.577924944812362,25.432782816541387,"['SELENOM', 'GPX4', 'SELENOS', 'RFK', 'SELENOW', 'PNPO', 'PLAT', 'KMO', 'SELENOK', 'SEPHS2', 'LDLR', 'SELENOH']",0.0359319641989125,0,0,12
12,miR-517 relationship with ARCN1 and USP1 WP3596,0.001679694180771927,inf,inf,"['ID2', 'USP1', 'ARCN1']",0.06760769077607005,0,0,3
13,Allograft Rejection WP2328,0.004996566678302808,3.719369038884813,19.70895240666628,"['ABCB1', 'TGFB1', 'COL5A1', 'HLA-B', 'HLA-C', 'HLA-A', 'VIM', 'HLA-F']",0.16685436798252734,0,0,8
14,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.005181812670264824,9.901975128017556,52.11013775043001,"['EBP', 'CYP51A1', 'DHCR24', 'DHCR7']",0.16685436798252734,0,0,4
15,Mevalonate pathway WP3963,0.005181812670264824,9.901975128017556,52.11013775043001,"['HMGCS1', 'MVD', 'HMGCR', 'ACAT2']",0.16685436798252734,0,0,4
16,ACE Inhibitor Pathway WP554,0.00612057941480467,22.267543859649123,113.477597113859,"['TGFB1', 'ATP6AP2', 'AGT']",0.18476499108441596,0,0,3
17,Endochondral Ossification with Skeletal Dysplasias WP4808,0.008412178236069111,2.64146110056926,12.621098807125096,"['GHR', 'ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'IGF1', 'SOX6', 'FGFR3', 'GLI3', 'RUNX2']",0.22572678266785448,0,0,11
18,Endochondral Ossification WP474,0.008412178236069111,2.64146110056926,12.621098807125096,"['GHR', 'ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'IGF1', 'SOX6', 'FGFR3', 'GLI3', 'RUNX2']",0.22572678266785448,0,0,11
19,miR-509-3p alteration of YAP1/ECM axis WP3967,0.009392966184898611,7.425749817117776,34.661871540916245,"['COL5A1', 'PBX3', 'FN1', 'GPC6']",0.23877908775294893,0,0,4
20,Monoamine GPCRs WP58,0.010850892074341497,4.053546453546454,18.336249744276284,"['HRH1', 'HTR7', 'HTR1F', 'CHRM5', 'ADRA1D', 'HTR4']",0.250989249316046,0,0,6
21,Proximal tubule transport WP4917,0.010912576057219391,3.131173494999421,14.146138946704944,"['ATP6V1G1', 'ABCB1', 'SLC3A1', 'ATP1A1', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.250989249316046,0,0,8
22,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.014139521630967173,inf,inf,"['TGFB1', 'VIP']",0.2741939945358543,0,0,2
23,COVID-19 adverse outcome pathway WP4891,0.014139521630967173,inf,inf,"['IL7', 'AGT']",0.2741939945358543,0,0,2
24,Gastric acid production WP2596,0.014139521630967173,inf,inf,"['CCK', 'VIP']",0.2741939945358543,0,0,2
25,Senescence and Autophagy in Cancer WP615,0.014192235742021444,2.0691986234021633,8.804564796571844,"['GABARAPL2', 'GABARAPL1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'FN1', 'PLAT', 'IGF1', 'CXCL14', 'GABARAP', 'MAP1LC3B', 'MAP1LC3A', 'IGFBP7', 'HRAS', 'SLC39A3']",0.2741939945358543,0,0,15
26,Imatinib and Chronic Myeloid Leukemia WP3640,0.01880810799100202,4.126403123474866,16.39612757239933,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'KIT']",0.3364561540612584,0,0,5
27,Peptide GPCRs WP24,0.01880810799100202,4.126403123474866,16.39612757239933,"['OPRD1', 'MC1R', 'OPRK1', 'NMBR', 'HCRTR2']",0.3364561540612584,0,0,5
28,Ferroptosis WP4313,0.020858953609158078,2.7033949176282266,10.462062617834631,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'GSS', 'VDAC3', 'SAT2', 'SLC7A11', 'FTL']",0.35981694975797684,0,0,8
29,Kynurenine Pathway and links to Cellular Senescence WP5044,0.023181192780698797,4.949524506217996,18.63205927067103,"['AHR', 'KMO', 'FOXO1', 'ACMSD']",0.37321720376925066,0,0,4
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.023181192780698797,4.949524506217996,18.63205927067103,"['IDI1', 'HMGCS1', 'MVD', 'HMGCR']",0.37321720376925066,0,0,4
31,Cardiac Progenitor Differentiation WP2406,0.024903836965299207,3.183987441130298,11.757616744815275,"['MESP1', 'TGFB1', 'TNNT2', 'KIT', 'THY1', 'IGF1']",0.3840500710572674,0,0,6
32,Cellular Proteostasis WP4918,0.025444311125947323,7.421052631578948,27.244636632846852,"['VBP1', 'PFDN5', 'PFDN6']",0.3840500710572674,0,0,3
33,NOTCH1 regulation of endothelial cell calcification WP3413,0.033064357864714525,4.242031560246629,14.462355561658189,"['ITGA1', 'PLAT', 'SOX6', 'FGFR3']",0.46970837790167985,0,0,4
34,TP53 network WP1742,0.033064357864714525,4.242031560246629,14.462355561658189,"['SUMO1', 'GADD45A', 'BAX', 'BBC3']",0.46970837790167985,0,0,4
35,Glycolysis and Gluconeogenesis WP534,0.0345938426931329,2.600623167155425,8.748703264857381,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'PFKM']",0.477395029165234,0,0,7
36,Photodynamic therapy-induced unfolded protein response WP3613,0.039032032585908025,2.7854395604395603,9.034218409500935,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'BBC3']",0.5236797705275993,0,0,6
37,Differentiation Pathway WP2848,0.043023763341240424,3.093887262079063,9.733377618405477,"['TGFB1', 'HGF', 'KIT', 'IGF1', 'FGF1']",0.5305986216368377,0,0,5
38,miRNA targets in ECM and membrane receptors WP2911,0.0450404627062326,3.7114118507681053,11.506096832836617,"['COL5A1', 'ITGA1', 'COL5A2', 'FN1']",0.5305986216368377,0,0,4
39,Nanomaterial induced apoptosis WP2507,0.0450404627062326,3.7114118507681053,11.506096832836617,"['ENDOG', 'HTRA2', 'BAX', 'CYCS']",0.5305986216368377,0,0,4
40,Statin inhibition of cholesterol production WP430,0.0450404627062326,3.7114118507681053,11.506096832836617,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.5305986216368377,0,0,4
41,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.0450404627062326,3.7114118507681053,11.506096832836617,"['TGFB1', 'FN1', 'VIM', 'RUNX2']",0.5305986216368377,0,0,4
42,Vitamin D Receptor Pathway WP2877,0.04768973960151075,1.859271523178808,5.657835769487632,"['ADAMTS5', 'SFRP1', 'ABCB1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'GADD45A', 'PNOC', 'TIMP2', 'TIMP3', 'CYP3A5', 'FOXO1']",0.5484320054173737,0,0,12
43,Pyrimidine metabolism WP4022,0.05001387834956527,1.7906643757159222,5.363854101079098,"['ENTPD1', 'NME2', 'NME3', 'NT5C', 'POLE4', 'POLE2', 'POLR1C', 'DPYD', 'POLE3', 'POLR2E', 'POLR2I', 'POLR2K', 'POLR2L']",0.5617837963451169,0,0,13
44,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.05911279284845358,3.298707632284809,9.329760912053791,"['OMG', 'IGF1', 'ASCL1', 'SOX6']",0.6374546969207991,0,0,4
45,Matrix Metalloproteinases WP129,0.059390189154111726,4.451754385964913,12.570090462678762,"['MMP16', 'TIMP2', 'TIMP3']",0.6374546969207991,0,0,3
46,Cytokines and Inflammatory Response WP530,0.07199798181363315,7.4163623082542,19.513318361893653,"['TGFB1', 'IL7']",0.702245189310238,0,0,2
47,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.07199798181363315,7.4163623082542,19.513318361893653,"['ID2', 'RUNX2']",0.702245189310238,0,0,2
48,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.07199798181363315,7.4163623082542,19.513318361893653,"['FN1', 'VIM']",0.702245189310238,0,0,2
49,Somatic sex determination WP4814,0.07199798181363315,7.4163623082542,19.513318361893653,"['FGF9', 'PTGDS']",0.702245189310238,0,0,2
50,Pregnane X receptor pathway WP2876,0.07523468167897487,2.9685442574981713,7.680048382588222,"['PSMC5', 'ABCB1', 'CYP3A5', 'FOXO1']",0.702245189310238,0,0,4
51,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.08008047582236914,2.4743777452415814,6.247118904307513,"['TGFBR3', 'TGFB1', 'HGF', 'MFGE8', 'HRAS']",0.702245189310238,0,0,5
52,Folate Metabolism WP176,0.08008047582236914,2.4743777452415814,6.247118904307513,"['AHCY', 'GPX4', 'RFK', 'PLAT', 'LDLR']",0.702245189310238,0,0,5
53,Development of ureteric collection system WP5053,0.08017984247794088,2.2274725274725276,5.620989359815707,"['GDF11', 'FRAS1', 'ANOS1', 'ETV4', 'GLI3', 'FREM2']",0.702245189310238,0,0,6
54,Alanine and aspartate metabolism WP106,0.08141973209394064,3.7094298245614037,9.303760515226097,"['GOT1', 'GAD1', 'GAD2']",0.702245189310238,0,0,3
55,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.08141973209394064,3.7094298245614037,9.303760515226097,"['SFRP1', 'SST', 'FOXO1']",0.702245189310238,0,0,3
56,Development and heterogeneity of the ILC family WP3893,0.08141973209394064,3.7094298245614037,9.303760515226097,"['IL7', 'ID2', 'AHR']",0.702245189310238,0,0,3
57,Nuclear Receptors Meta-Pathway WP2882,0.08585608259980522,1.3828465215082315,3.3950027689946944,"['ABCB1', 'CDKN1B', 'SLC7A11', 'AHR', 'SLC6A1', 'CYP3A5', 'SLC5A4', 'FOXO1', 'RGS2', 'SLC39A7', 'CBR3', 'SLC39A3', 'TGFB1', 'HGF', 'SLC2A12', 'AIP', 'SLC39A13', 'CES4A', 'TGFBR3', 'PSMC5', 'SCD', 'B3GNT5', 'BAX', 'MFGE8', 'FKBP5', 'FTL']",0.7275173315036126,0,0,26
58,One-carbon metabolism WP241,0.09331694141282382,2.698410587218195,6.399965045088508,"['ALDH1L1', 'AHCY', 'CHDH', 'GLRX']",0.7492160466368976,0,0,4
59,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.09331694141282382,2.698410587218195,6.399965045088508,"['HMGCS1', 'SCD', 'HMGCR', 'LDLR']",0.7492160466368976,0,0,4
60,Striated Muscle Contraction Pathway WP383,0.09331694141282382,2.698410587218195,6.399965045088508,"['MYOM1', 'TNNT2', 'VIM', 'ACTG1']",0.7492160466368976,0,0,4
61,Computational Model of Aerobic Glycolysis WP4629,0.1063791252019334,3.1791979949874687,7.123774913993602,"['LDHA', 'PKM', 'PFKM']",0.7492160466368976,0,0,3
62,Cysteine and methionine catabolism WP4504,0.1063791252019334,3.1791979949874687,7.123774913993602,"['AHCY', 'GOT1', 'GSS']",0.7492160466368976,0,0,3
63,Glycolysis in senescence WP5049,0.1063791252019334,3.1791979949874687,7.123774913993602,"['LDHA', 'PKM', 'ALDOC']",0.7492160466368976,0,0,3
64,Mammalian disorder of sexual development WP4842,0.1063791252019334,3.1791979949874687,7.123774913993602,"['MAPK11', 'FGF9', 'PTGDS']",0.7492160466368976,0,0,3
65,GABA receptor Signaling WP4159,0.10729165460110368,2.0245754245754246,4.519266188458612,"['GABBR1', 'SLC32A1', 'GAD1', 'GAD2', 'SLC6A1', 'GABRD']",0.7492160466368976,0,0,6
66,"GPCRs, Other WP117",0.10729165460110368,2.0245754245754246,4.519266188458612,"['PTGFR', 'HTR7', 'ADGRV1', 'HTR1F', 'F2R', 'ADRA1D']",0.7492160466368976,0,0,6
67,Dopaminergic Neurogenesis WP2855,0.11069810858662707,4.943754565376187,10.880949320366145,"['TGFB1', 'ASCL1']",0.7492160466368976,0,0,2
68,Aryl Hydrocarbon Receptor Pathway WP2873,0.11181851220588679,2.1828438549651192,4.782344903936166,"['CDKN1B', 'TGFB1', 'AIP', 'BAX', 'AHR']",0.7492160466368976,0,0,5
69,Oxysterols derived from cholesterol WP4545,0.11181851220588679,2.1828438549651192,4.782344903936166,"['EBP', 'DBP', 'INSIG1', 'ACOT2', 'DHCR7']",0.7492160466368976,0,0,5
70,Apoptosis Modulation and Signaling WP1772,0.11194341555385673,1.650746999755082,3.6147426449698274,"['HRK', 'ENDOG', 'PTRH2', 'HTRA2', 'CYCS', 'BAX', 'PRKD1', 'PTPN13', 'BCL2L2', 'BBC3']",0.7492160466368976,0,0,10
71,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.11277723188238897,1.6024221453287197,3.497031235076698,"['IDI1', 'SQLE', 'HMGCS1', 'SCD', 'INSIG1', 'CYP51A1', 'MVD', 'HMGCR', 'LSS', 'LDLR', 'FDFT1']",0.7492160466368976,0,0,11
72,Methionine De Novo and Salvage Pathway WP3580,0.11323555156209839,2.473299195318215,5.387550791888429,"['AHCY', 'CHDH', 'ODC1', 'SRM']",0.7492160466368976,0,0,4
73,Nucleotide metabolism WP404,0.11323555156209839,2.473299195318215,5.387550791888429,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.7492160466368976,0,0,4
74,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.11894820724778295,inf,inf,['FMO5'],0.7559471592194628,0,0,1
75,Codeine and Morphine Metabolism WP1604,0.11894820724778295,inf,inf,['ABCB1'],0.7559471592194628,0,0,1
76,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.11894820724778295,inf,inf,['AGT'],0.7559471592194628,0,0,1
77,Spinal Cord Injury WP2431,0.12257254386122006,1.614701466313133,3.3893427128253886,"['TGFB1', 'CDKN1B', 'GADD45A', 'APEX1', 'CCNG1', 'OMG', 'XYLT1', 'SLIT3', 'VIM', 'TNFSF13B']",0.7688641387658349,0,0,10
78,7-oxo-C and 7beta-HC pathways WP5064,0.13483918838216513,2.282820325249001,4.5740240975571504,"['EBP', 'DBP', 'ACOT2', 'DHCR7']",0.8140915998573219,0,0,4
79,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.13483918838216513,2.282820325249001,4.5740240975571504,"['FBN2', 'TGFBR3', 'ANGPT2', 'RUNX2']",0.8140915998573219,0,0,4
80,Sleep regulation WP3591,0.13483918838216513,2.282820325249001,4.5740240975571504,"['AHCY', 'CRH', 'PTGDS', 'HCRTR2']",0.8140915998573219,0,0,4
81,Parkinson's disease pathway WP2371,0.13849958023113929,1.8554945054945056,3.668104792626763,"['MAPK11', 'PINK1', 'HTRA2', 'CYCS', 'UBE2L6', 'PARK7']",0.8258678673042009,0,0,6
82,Adipogenesis WP236,0.1531753122393638,1.4611515217312634,2.741371838647971,"['LIPE', 'SFRP4', 'WWTR1', 'TGFB1', 'GADD45A', 'SCD', 'DDIT3', 'NDN', 'AHR', 'IGF1', 'FOXO1', 'AGT']",0.8611161731827235,0,0,12
83,Biogenic Amine Synthesis WP550,0.1533250329062406,3.7074506939371803,6.952193793157797,"['GAD1', 'GAD2']",0.8611161731827235,0,0,2
84,Eicosanoid Synthesis WP167,0.1533250329062406,3.7074506939371803,6.952193793157797,"['PTGES2', 'PTGDS']",0.8611161731827235,0,0,2
85,IL1 and megakaryocytes in obesity WP2865,0.1533250329062406,3.7074506939371803,6.952193793157797,"['F2R', 'TIMP2']",0.8611161731827235,0,0,2
86,Sulfation Biotransformation Reaction WP692,0.1533250329062406,3.7074506939371803,6.952193793157797,"['SULT4A1', 'PAPSS2']",0.8611161731827235,0,0,2
87,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.15863291032161517,1.6760003783937187,3.0857890234334873,"['BEX3', 'CDKN1B', 'HSPA5', 'F2R', 'PTK2B', 'RNF7', 'VIM']",0.8806861573027601,0,0,7
88,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.16348276120116098,2.4722222222222223,4.477312444308597,"['CD81', 'IGF1', 'PDLIM5']",0.8872154343838287,0,0,3
89,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.16348276120116098,2.4722222222222223,4.477312444308597,"['TGFB1', 'FN1', 'IGFBP7']",0.8872154343838287,0,0,3
90,DNA Mismatch Repair WP531,0.1824016559574655,1.978054133138259,3.3657463845624145,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.9465726574279099,0,0,4
91,Unfolded protein response WP4925,0.1824016559574655,1.978054133138259,3.3657463845624145,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.9465726574279099,0,0,4
92,Proteasome Degradation WP183,0.18681504596116874,1.4845814977973568,2.4905876782921768,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10']",0.9465726574279099,0,0,9
93,NRF2 pathway WP2884,0.18765919024195402,1.3922461368653423,2.329405687013374,"['TGFB1', 'HGF', 'SLC2A12', 'SLC39A13', 'SLC39A7', 'SLC7A11', 'SLC6A1', 'SLC5A4', 'CES4A', 'SLC39A3', 'FTL', 'CBR3']",0.9465726574279099,0,0,12
94,Base Excision Repair WP4752,0.18983051292110442,1.7663668688558878,2.9350369500561615,"['POLE4', 'NEIL2', 'APEX1', 'POLE2', 'POLE3']",0.9465726574279099,0,0,5
95,Exercise-induced Circadian Regulation WP410,0.19163717559950344,1.5741135697147428,2.600673946036719,"['PER2', 'IDI1', 'DAZAP2', 'SUMO1', 'RBPMS', 'EIF4G2', 'HERPUD1']",0.9465726574279099,0,0,7
96,IL-18 signaling pathway WP4754,0.1918145471440034,1.2576267320522325,2.076626302884985,"['TOMM40', 'TICAM2', 'USP5', 'EPB41', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'FN1', 'NDUFC1', 'RUNX2', 'CENPB', 'ADAMTS5', 'ARL4D', 'TMSB4X', 'RFX5', 'TIMP3', 'CYCS', 'BAX', 'B2M', 'ITM2C', 'ARF6']",0.9465726574279099,0,0,22
97,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.19479375922718759,2.224780701754386,3.6393272522420657,"['MAPK11', 'FGF9', 'GADD45G']",0.9465726574279099,0,0,3
98,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.19479375922718759,2.224780701754386,3.6393272522420657,"['BAX', 'BCL2L14', 'BCL2L2']",0.9465726574279099,0,0,3
99,Dual hijack model of Vif in HIV infection WP3300,0.19839857515402773,2.9656683710737766,4.7969011682340055,"['ELOB', 'RUNX1']",0.9465726574279099,0,0,2
100,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.19839857515402773,2.9656683710737766,4.7969011682340055,"['GALNT3', 'FGFR3']",0.9465726574279099,0,0,2
101,Osteoclast Signaling WP12,0.19839857515402773,2.9656683710737766,4.7969011682340055,"['AIMP2', 'ATP6V1G1']",0.9465726574279099,0,0,2
102,Androgen receptor signaling pathway WP138,0.19989733138229152,1.3706911190354898,2.2067460686897884,"['SUMO1', 'KAT5', 'BAG1', 'RNF6', 'STUB1', 'PARK7', 'CALR', 'FKBP4', 'ETV5', 'RUNX2', 'FOXO1', 'RAN']",0.9465726574279099,0,0,12
103,Glycosylation and related congenital defects WP4521,0.20798195468708583,1.8542428675932698,2.911724916590175,"['DPM2', 'DPM3', 'MPI', 'MPDU1']",0.9710790041557786,0,0,4
104,Modulators of TCR signaling and T cell activation WP5072,0.20909361580165833,1.5276651716405036,2.3907550595368536,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'RNF7', 'CD247', 'ZFP36L1']",0.9710790041557786,0,0,7
105,Genotoxicity pathway WP4286,0.21147918067047386,1.589795918367347,2.4699526007145836,"['RPS27', 'GADD45A', 'BLOC1S2', 'ID2', 'PCDH8', 'PHLDA3']",0.9728042310841797,0,0,6
106,Composition of Lipid Particles WP3601,0.2237569184472057,7.411678832116788,11.09672850291657,['LDLR'],0.9999902347269571,0,0,1
107,Drug Induction of Bile Acid Pathway WP2289,0.2237569184472057,7.411678832116788,11.09672850291657,['ABCB1'],0.9999902347269571,0,0,1
108,EV release from cardiac cells and their functional effects WP3297,0.2237569184472057,7.411678832116788,11.09672850291657,['RGS16'],0.9999902347269571,0,0,1
109,Lung fibrosis WP3624,0.23450097544990883,1.744997633288868,2.530762269868268,"['TGFB1', 'HGF', 'IGF1', 'FGF1']",0.9999902347269571,0,0,4
110,Oncostatin M Signaling Pathway WP2374,0.23888844047153576,1.4132690493658946,2.023460132918607,"['CDKN1B', 'PRKCH', 'PRKCD', 'RPS6', 'TIMP3', 'PTK2B', 'HRAS', 'LDLR']",0.9999902347269571,0,0,8
111,Galanin receptor pathway WP4970,0.24473470975342868,2.4711468224981736,3.47833801188203,"['CDKN1B', 'PRKCD']",0.9999902347269571,0,0,2
112,Glutathione metabolism WP100,0.24473470975342868,2.4711468224981736,3.47833801188203,"['GPX4', 'GSS']",0.9999902347269571,0,0,2
113,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.24473470975342868,2.4711468224981736,3.47833801188203,"['SFRP1', 'TGFB1']",0.9999902347269571,0,0,2
114,Trans-sulfuration pathway WP2333,0.24473470975342868,2.4711468224981736,3.47833801188203,"['AHCY', 'GOT1']",0.9999902347269571,0,0,2
115,miRNA regulation of DNA damage response WP1530,0.2456406981304123,1.4425097751710656,2.025118394598152,"['CDKN1B', 'GADD45A', 'CCNG1', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999902347269571,0,0,7
116,Constitutive Androstane Receptor Pathway WP2875,0.26092174583285865,1.8536184210526316,2.4904007452620576,"['ABCB1', 'CYP3A5', 'FOXO1']",0.9999902347269571,0,0,3
117,Type II interferon signaling (IFNG) WP619,0.26092174583285865,1.8536184210526316,2.4904007452620576,"['PRKCD', 'HLA-B', 'IFIT2']",0.9999902347269571,0,0,3
118,Biomarkers for pyrimidine metabolism disorders WP4584,0.29139613085108085,2.117917144944172,2.6115436162292207,"['NT5C', 'DPYD']",0.9999902347269571,0,0,2
119,Genes targeted by miRNAs in adipocytes WP1992,0.29139613085108085,2.117917144944172,2.6115436162292207,"['TMSB4X', 'IGF1']",0.9999902347269571,0,0,2
120,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.29139613085108085,2.117917144944172,2.6115436162292207,"['TULP3', 'SOX4']",0.9999902347269571,0,0,2
121,Major receptors targeted by epinephrine and norepinephrine WP4589,0.29139613085108085,2.117917144944172,2.6115436162292207,"['ADCY10', 'ADRA1D']",0.9999902347269571,0,0,2
122,Purine metabolism WP4792,0.29139613085108085,2.117917144944172,2.6115436162292207,"['PRPS1', 'APRT']",0.9999902347269571,0,0,2
123,Pyrimidine metabolism and related diseases WP4225,0.29139613085108085,2.117917144944172,2.6115436162292207,"['NT5C', 'DPYD']",0.9999902347269571,0,0,2
124,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.29500317297383943,1.710863697705803,2.088569650853579,"['MAPK11', 'BAX', 'BBC3']",0.9999902347269571,0,0,3
125,Pre-implantation embryo WP3527,0.29500317297383943,1.710863697705803,2.088569650853579,"['DLX2', 'DDIT3', 'ATP1A1']",0.9999902347269571,0,0,3
126,Proteoglycan biosynthesis WP4784,0.29500317297383943,1.710863697705803,2.088569650853579,"['XYLT1', 'B4GALT7', 'PAPSS2']",0.9999902347269571,0,0,3
127,Zinc homeostasis WP3529,0.29500317297383943,1.710863697705803,2.088569650853579,"['SLC39A13', 'SLC39A7', 'SLC39A3']",0.9999902347269571,0,0,3
128,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3060080319897178,1.4259770244396892,1.6885620364433862,"['HGF', 'ITGA1', 'GAB1', 'PTK2B', 'HRAS']",0.9999902347269571,0,0,5
129,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.3159003504273658,1.1315143333454136,1.3038761713349174,"['CDKN1B', 'COL11A1', 'HIF3A', 'FGF1', 'FOXO1', 'GHR', 'LIPE', 'RELN', 'FGF9', 'GNG4', 'PDGFC', 'HRAS', 'ANGPT2', 'HGF', 'RPS6', 'F2R', 'FN1', 'VEGFB', 'IGF1', 'COL5A1', 'PIK3IP1', 'DDIT4', 'KIT', 'COL5A2', 'FGFR3']",0.9999902347269571,0,0,25
130,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.3161057452805494,3.7054744525547445,4.2675152015379325,['GSS'],0.9999902347269571,0,0,1
131,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.3161057452805494,3.7054744525547445,4.2675152015379325,['ABCB1'],0.9999902347269571,0,0,1
132,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3161057452805494,3.7054744525547445,4.2675152015379325,['BAX'],0.9999902347269571,0,0,1
133,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.3161057452805494,3.7054744525547445,4.2675152015379325,['CD247'],0.9999902347269571,0,0,1
134,Platelet-mediated interactions with vascular and circulating cells WP4462,0.3161057452805494,3.7054744525547445,4.2675152015379325,['TGFB1'],0.9999902347269571,0,0,1
135,Small Ligand GPCRs WP247,0.3161057452805494,3.7054744525547445,4.2675152015379325,['PTGFR'],0.9999902347269571,0,0,1
136,Tamoxifen metabolism WP691,0.3161057452805494,3.7054744525547445,4.2675152015379325,['CYP3A5'],0.9999902347269571,0,0,1
137,Tgif disruption of Shh signaling WP3674,0.3161057452805494,3.7054744525547445,4.2675152015379325,['GLI3'],0.9999902347269571,0,0,1
138,Vitamin B6-dependent and responsive disorders WP4228,0.3161057452805494,3.7054744525547445,4.2675152015379325,['PNPO'],0.9999902347269571,0,0,1
139,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3177673320168083,1.4828090709583028,1.6999454395740092,"['LDHA', 'ANGPT2', 'PKM', 'BAX']",0.9999902347269571,0,0,4
140,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.3293240217935584,1.5885025062656641,1.7643706133170887,"['HTR7', 'RPS6KA5', 'HTR4']",0.9999902347269571,0,0,3
141,"GPCRs, Class B Secretin-like WP334",0.3376503754781624,1.8529948867786705,2.011878656499084,"['VIPR2', 'ADGRG2']",0.9999902347269571,0,0,2
142,Bladder cancer WP2828,0.34615275325044187,1.4120597763611662,1.4980190818232522,"['RPS6KA5', 'DAPK2', 'HRAS', 'FGFR3']",0.9999902347269571,0,0,4
143,One-carbon metabolism and related pathways WP3940,0.3552938841863159,1.3238600711148296,1.369943625894241,"['GPX4', 'CHDH', 'GAD1', 'GSS', 'GAD2']",0.9999902347269571,0,0,5
144,DNA damage response WP707,0.36071574139948887,1.2709576138147567,1.295951059821001,"['CDKN1B', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999902347269571,0,0,6
145,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.36071574139948887,1.2709576138147567,1.295951059821001,"['PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3']",0.9999902347269571,0,0,6
146,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.363597555634427,1.4824561403508771,1.4998122022372955,"['B3GALNT1', 'B3GALT2', 'B3GALT1']",0.9999902347269571,0,0,3
147,Oxidation by Cytochrome P450 WP43,0.363597555634427,1.4824561403508771,1.4998122022372955,"['CYB5R1', 'CYP51A1', 'CYP3A5']",0.9999902347269571,0,0,3
148,Nanoparticle-mediated activation of receptor signaling WP2643,0.3745749719171761,1.3477422358183149,1.3234334188587744,"['MAPK11', 'ITGA1', 'FN1', 'HRAS']",0.9999902347269571,0,0,4
149,Cell Differentiation - Index expanded WP2023,0.3829344079380333,1.6469442415388362,1.5808878823745551,"['ID2', 'RUNX2']",0.9999902347269571,0,0,2
150,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3829344079380333,1.6469442415388362,1.5808878823745551,"['RYR1', 'CCK']",0.9999902347269571,0,0,2
151,Cori Cycle WP1946,0.3829344079380333,1.6469442415388362,1.5808878823745551,"['LDHA', 'PGAM1']",0.9999902347269571,0,0,2
152,Overview of nanoparticle effects WP3287,0.3829344079380333,1.6469442415388362,1.5808878823745551,"['FN1', 'BAX']",0.9999902347269571,0,0,2
153,TYROBP causal network in microglia WP3945,0.3829344079380333,1.6469442415388362,1.5808878823745551,"['DPYD', 'LHFPL2']",0.9999902347269571,0,0,2
154,Endometrial cancer WP4155,0.38441890947121166,1.2068471663370388,1.153772937577281,"['GADD45A', 'TCF7', 'BAX', 'FGF1', 'HRAS', 'FGFR3', 'GADD45G']",0.9999902347269571,0,0,7
155,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.38441890947121166,1.2068471663370388,1.153772937577281,"['MAPK11', 'ANGPT2', 'FN1', 'BAX', 'HRAS', 'ANGPTL1', 'FOXO1']",0.9999902347269571,0,0,7
156,Bile acids synthesis and enterohepatic circulation  WP4389,0.39747497659779024,2.47007299270073,2.2789468928629826,['LDLR'],0.9999902347269571,0,0,1
157,Blood Clotting Cascade WP272,0.39747497659779024,2.47007299270073,2.2789468928629826,['PLAT'],0.9999902347269571,0,0,1
158,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.39747497659779024,2.47007299270073,2.2789468928629826,['LDLR'],0.9999902347269571,0,0,1
159,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.39747497659779024,2.47007299270073,2.2789468928629826,['VEGFB'],0.9999902347269571,0,0,1
160,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.39747497659779024,2.47007299270073,2.2789468928629826,['STRADB'],0.9999902347269571,0,0,1
161,Nanoparticle triggered regulated necrosis WP2513,0.39747497659779024,2.47007299270073,2.2789468928629826,['FTL'],0.9999902347269571,0,0,1
162,Role of Osx and miRNAs in tooth development WP3971,0.39747497659779024,2.47007299270073,2.2789468928629826,['RUNX2'],0.9999902347269571,0,0,1
163,IL-7 signaling pathway WP205,0.3975717771457683,1.3896655701754386,1.2817994364452854,"['CDKN1B', 'IL7', 'PTK2B']",0.9999902347269571,0,0,3
164,Osteoblast differentiation WP4787,0.4026701539419714,1.150349384778976,1.0464009715591605,"['MAPK11', 'PRKCH', 'FGF9', 'PRKCD', 'PRKD1', 'FGF1', 'FGFR3', 'RUNX2', 'GLI3']",0.9999902347269571,0,0,9
165,Myometrial relaxation and contraction pathways WP289,0.4086735842378572,1.1042349362642876,0.9881119606537583,"['RYR1', 'PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'ACTG1', 'RGS2', 'PRKAR1A', 'GNG4', 'CRH', 'CALM3', 'PRKD1', 'ATF5', 'CORIN']",0.9999902347269571,0,0,14
166,Calcium Regulation in the Cardiac Cell WP536,0.4226655242198967,1.0925028119303417,0.9408351647117823,"['RYR1', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B2', 'GJD2', 'RGS2', 'PRKAR1A', 'GNG4', 'CALM3', 'PRKD1', 'CALR']",0.9999902347269571,0,0,14
167,Airway smooth muscle cell contraction WP4962,0.42682472212055017,1.4821037253469687,1.261836192108014,"['RYR1', 'MYLK']",0.9999902347269571,0,0,2
168,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.42682472212055017,1.4821037253469687,1.261836192108014,"['PTGFR', 'PTGDS']",0.9999902347269571,0,0,2
169,ERK Pathway in Huntington's Disease WP3853,0.42682472212055017,1.4821037253469687,1.261836192108014,"['RPS6KA5', 'HRAS']",0.9999902347269571,0,0,2
170,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.42682472212055017,1.4821037253469687,1.261836192108014,"['ABCD2', 'ABCB1']",0.9999902347269571,0,0,2
171,Phytochemical activity on NRF2 transcriptional activation WP3,0.42682472212055017,1.4821037253469687,1.261836192108014,"['AIMP2', 'SLC7A11']",0.9999902347269571,0,0,2
172,Type II diabetes mellitus WP1584,0.42682472212055017,1.4821037253469687,1.261836192108014,"['SURF1', 'PRKCD']",0.9999902347269571,0,0,2
173,Urea cycle and metabolism of amino groups WP497,0.42682472212055017,1.4821037253469687,1.261836192108014,"['ODC1', 'SRM']",0.9999902347269571,0,0,2
174,DNA Replication WP466,0.4309480420808575,1.2351865398683248,1.0397401922248977,"['RPA3', 'POLE2', 'GMNN', 'MCM6']",0.9999902347269571,0,0,4
175,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.43102879289239293,1.3077915376676987,1.1006117074113948,"['MAPK11', 'FGF9', 'FGFR3']",0.9999902347269571,0,0,3
176,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4381270102268683,1.111784140969163,0.9174958965498293,"['SHC3', 'HGF', 'RPS6', 'PDGFC', 'GAB1', 'BAX', 'IGF1', 'HRAS', 'FGFR3']",0.9999902347269571,0,0,9
177,Breast cancer pathway WP4262,0.46326096066822064,1.0726489938080495,0.8253655938513541,"['SFRP4', 'SHC3', 'FGF9', 'GADD45A', 'TCF7', 'KIT', 'BAX', 'IGF1', 'FGF1', 'HRAS', 'GADD45G']",0.9999902347269571,0,0,11
178,Cannabinoid receptor signaling WP3869,0.4637834156102336,1.235014619883041,0.9489081843597,"['MAPK11', 'PRKAR1A', 'AHR']",0.9999902347269571,0,0,3
179,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4637834156102336,1.235014619883041,0.9489081843597,"['RAB3B', 'RAB3A', 'RAB11A']",0.9999902347269571,0,0,3
180,Kallmann's Syndrome WP5074,0.4690121516726014,1.347234212099077,1.0200268599216158,"['ANOS1', 'ASCL1']",0.9999902347269571,0,0,2
181,Omega-9 FA synthesis WP4724,0.4690121516726014,1.347234212099077,1.0200268599216158,"['SCD', 'ACOT2']",0.9999902347269571,0,0,2
182,Farnesoid X receptor pathway WP2879,0.4691691615783282,1.8523722627737227,1.4018603055414187,['FKBP5'],0.9999902347269571,0,0,1
183,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.4691691615783282,1.8523722627737227,1.4018603055414187,['ALDH1L1'],0.9999902347269571,0,0,1
184,Inflammatory Response Pathway WP453,0.4691691615783282,1.8523722627737227,1.4018603055414187,['FN1'],0.9999902347269571,0,0,1
185,Irinotecan pathway WP229,0.4691691615783282,1.8523722627737227,1.4018603055414187,['CYP3A5'],0.9999902347269571,0,0,1
186,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.4691691615783282,1.8523722627737227,1.4018603055414187,['ACOT2'],0.9999902347269571,0,0,1
187,Liver X receptor pathway WP2874,0.4691691615783282,1.8523722627737227,1.4018603055414187,['SCD'],0.9999902347269571,0,0,1
188,miRNA Biogenesis WP2338,0.4691691615783282,1.8523722627737227,1.4018603055414187,['RAN'],0.9999902347269571,0,0,1
189,Mitochondrial fatty acid synthesis pathway WP4317,0.4691691615783282,1.8523722627737227,1.4018603055414187,['HSD17B12'],0.9999902347269571,0,0,1
190,NAD Biosynthesis II (from tryptophan) WP2485,0.4691691615783282,1.8523722627737227,1.4018603055414187,['KMO'],0.9999902347269571,0,0,1
191,Peroxiredoxin 2 induced ovarian failure WP4873,0.4691691615783282,1.8523722627737227,1.4018603055414187,['BAX'],0.9999902347269571,0,0,1
192,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.4691691615783282,1.8523722627737227,1.4018603055414187,['FOXO1'],0.9999902347269571,0,0,1
193,Vitamin D Metabolism WP1531,0.4691691615783282,1.8523722627737227,1.4018603055414187,['DHCR7'],0.9999902347269571,0,0,1
194,Acute viral myocarditis WP4298,0.4714173100620372,1.1115384615384616,0.8358897820378752,"['SGCD', 'ENDOG', 'TGFB1', 'CYCS', 'BAX', 'EIF4G2']",0.9999902347269571,0,0,6
195,Synaptic Vesicle Pathway WP2267,0.4714173100620372,1.1115384615384616,0.8358897820378752,"['RAB3A', 'SLC32A1', 'SLC17A7', 'PARK7', 'SYN3', 'CPLX3']",0.9999902347269571,0,0,6
196,Translation Factors WP107,0.4714173100620372,1.1115384615384616,0.8358897820378752,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H', 'EIF3D']",0.9999902347269571,0,0,6
197,Ethanol effects on histone modifications WP3996,0.4956812432120335,1.1698984302862419,0.8210607061041011,"['AHCY', 'HDAC10', 'HAT1']",0.9999902347269571,0,0,3
198,Eukaryotic Transcription Initiation WP405,0.5017783184079426,1.089591766428387,0.7513790538591808,"['TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR2K']",0.9999902347269571,0,0,5
199,G1 to S cell cycle control WP45,0.5017783184079426,1.089591766428387,0.7513790538591808,"['CDKN1B', 'GADD45A', 'RPA3', 'POLE2', 'MCM6']",0.9999902347269571,0,0,5
200,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5053970608468479,1.0584415584415585,0.7222920560107188,"['TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999902347269571,0,0,7
201,Complement and Coagulation Cascades WP558,0.5092806920967335,1.2348429510591672,0.8332176365424295,"['F2R', 'PLAT']",0.9999902347269571,0,0,2
202,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5092806920967335,1.2348429510591672,0.8332176365424295,"['BAX', 'BBC3']",0.9999902347269571,0,0,2
203,Purinergic signaling WP4900,0.5092806920967335,1.2348429510591672,0.8332176365424295,"['P2RY12', 'P2RY14']",0.9999902347269571,0,0,2
204,Triacylglyceride synthesis WP325,0.5092806920967335,1.2348429510591672,0.8332176365424295,"['LIPE', 'AGPAT1']",0.9999902347269571,0,0,2
205,Urea cycle and associated pathways WP4595,0.5092806920967335,1.2348429510591672,0.8332176365424295,"['GOT1', 'MDH2']",0.9999902347269571,0,0,2
206,Vitamin B12 metabolism WP1533,0.5092806920967335,1.2348429510591672,0.8332176365424295,"['PLAT', 'LDLR']",0.9999902347269571,0,0,2
207,Integrated Cancer Pathway WP1971,0.5125023427880369,1.0976184670405593,0.7337030606560744,"['CDKN1B', 'BAX', 'BACH1', 'BBC3']",0.9999902347269571,0,0,4
208,p38 MAPK Signaling Pathway WP400,0.5125023427880369,1.0976184670405593,0.7337030606560744,"['RPS6KA5', 'DDIT3', 'HRAS', 'HMGN1']",0.9999902347269571,0,0,4
209,Target Of Rapamycin (TOR) Signaling WP1471,0.5125023427880369,1.0976184670405593,0.7337030606560744,"['IDI1', 'RRAGA', 'DDIT4', 'HMGCR']",0.9999902347269571,0,0,4
210,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5323379503900392,1.4817518248175183,0.9342100692301157,['TCF7'],0.9999902347269571,0,0,1
211,Aspirin and miRNAs WP4707,0.5323379503900392,1.4817518248175183,0.9342100692301157,['MVD'],0.9999902347269571,0,0,1
212,Biomarkers for urea cycle disorders WP4583,0.5323379503900392,1.4817518248175183,0.9342100692301157,['GOT1'],0.9999902347269571,0,0,1
213,Caloric restriction and aging WP4191,0.5323379503900392,1.4817518248175183,0.9342100692301157,['IGF1'],0.9999902347269571,0,0,1
214,"Degradation pathway of sphingolipids, including diseases WP4153",0.5323379503900392,1.4817518248175183,0.9342100692301157,['NEU1'],0.9999902347269571,0,0,1
215,Disorders of Folate Metabolism and Transport WP4259,0.5323379503900392,1.4817518248175183,0.9342100692301157,['ALDH1L1'],0.9999902347269571,0,0,1
216,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5323379503900392,1.4817518248175183,0.9342100692301157,['RPS6'],0.9999902347269571,0,0,1
217,Insulin signaling in adipocytes (normal condition) WP3634,0.5323379503900392,1.4817518248175183,0.9342100692301157,['RPS6'],0.9999902347269571,0,0,1
218,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5323379503900392,1.4817518248175183,0.9342100692301157,['AHCY'],0.9999902347269571,0,0,1
219,Methylation Pathways WP704,0.5323379503900392,1.4817518248175183,0.9342100692301157,['NNMT'],0.9999902347269571,0,0,1
220,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5323379503900392,1.4817518248175183,0.9342100692301157,['TGFB1'],0.9999902347269571,0,0,1
221,Transcriptional cascade regulating adipogenesis WP4211,0.5323379503900392,1.4817518248175183,0.9342100692301157,['DDIT3'],0.9999902347269571,0,0,1
222,Aryl Hydrocarbon Receptor Netpath WP2586,0.5384934371514808,1.0583133033754832,0.6550747364952925,"['CDKN1B', 'AIP', 'AHR', 'HRAS']",0.9999902347269571,0,0,4
223,Nephrotic syndrome WP4758,0.5384934371514808,1.0583133033754832,0.6550747364952925,"['ANLN', 'INF2', 'GPC5', 'WDR73']",0.9999902347269571,0,0,4
224,Gastric Cancer Network 1 WP2361,0.5474897378277582,1.1397426532561667,0.6865941510695299,"['ACTL6A', 'KIF15']",0.9999902347269571,0,0,2
225,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5474897378277582,1.1397426532561667,0.6865941510695299,"['EIF3I', 'EIF3D']",0.9999902347269571,0,0,2
226,p53 transcriptional gene network WP4963,0.5479310245316122,1.0288555392874572,0.6189655293472338,"['GADD45A', 'CCNG1', 'BAX', 'SLC7A11', 'BBC3']",0.9999902347269571,0,0,5
227,Apoptosis WP254,0.555934588724711,1.0100899100899101,0.5930284708400704,"['HRK', 'CYCS', 'BAX', 'IGF1', 'BCL2L2', 'BBC3']",0.9999902347269571,0,0,6
228,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5564291101390786,1.0582706766917294,0.6203746755395366,"['CALM3', 'AGT', 'CAMK1G']",0.9999902347269571,0,0,3
229,The influence of laminopathies on Wnt signaling WP4844,0.5564291101390786,1.0582706766917294,0.6203746755395366,"['ICMT', 'TCF7', 'RUNX2']",0.9999902347269571,0,0,3
230,TGF-beta Receptor Signaling WP560,0.5637623259500181,1.0217188406528264,0.5855700809688331,"['TGFBR3', 'TGFB1', 'HRAS', 'RUNX2']",0.9999902347269571,0,0,4
231,Phosphodiesterases in neuronal function WP4222,0.5702213264075116,1.0009497051956788,0.5622641801422057,"['ADCY10', 'PDE10A', 'PDE1A', 'PDE3A', 'PDE5A']",0.9999902347269571,0,0,5
232,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5835592223278272,1.0582281122821664,0.569971542388957,"['H3F3B', 'H2AFZ']",0.9999902347269571,0,0,2
233,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5835592223278272,1.0582281122821664,0.569971542388957,"['FGF1', 'RUNX2']",0.9999902347269571,0,0,2
234,Monoamine Transport WP727,0.5835592223278272,1.0582281122821664,0.569971542388957,"['SLC6A1', 'AGT']",0.9999902347269571,0,0,2
235,Ovarian infertility WP34,0.5835592223278272,1.0582281122821664,0.569971542388957,"['CDKN1B', 'INHA']",0.9999902347269571,0,0,2
236,Prostaglandin Synthesis and Regulation WP98,0.5835592223278272,1.0582281122821664,0.569971542388957,"['PTGFR', 'PTGDS']",0.9999902347269571,0,0,2
237,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5835592223278272,1.0582281122821664,0.569971542388957,"['PTGES2', 'HRAS']",0.9999902347269571,0,0,2
238,SARS-CoV-2 mitochondrial interactions WP5038,0.5835592223278272,1.0582281122821664,0.569971542388957,"['NDUFB9', 'PHB']",0.9999902347269571,0,0,2
239,Oxidative Damage WP3941,0.5851031397048708,1.010067783094099,0.5413631410148719,"['CDKN1B', 'GADD45A', 'CYCS']",0.9999902347269571,0,0,3
240,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5851031397048708,1.010067783094099,0.5413631410148719,"['CDKN1B', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,3
241,Cancer immunotherapy by PD-1 blockade WP4585,0.5879944730729388,1.2346715328467153,0.65565716891775,['HLA-A'],0.9999902347269571,0,0,1
242,"Cerebral organic acidurias, including diseases WP4519",0.5879944730729388,1.2346715328467153,0.65565716891775,['MDH2'],0.9999902347269571,0,0,1
243,HIF1A and PPARG regulation of glycolysis WP2456,0.5879944730729388,1.2346715328467153,0.65565716891775,['LDHA'],0.9999902347269571,0,0,1
244,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5879944730729388,1.2346715328467153,0.65565716891775,['TGFB1'],0.9999902347269571,0,0,1
245,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5879944730729388,1.2346715328467153,0.65565716891775,['ANAPC11'],0.9999902347269571,0,0,1
246,Thiamine metabolic pathways WP4297,0.5879944730729388,1.2346715328467153,0.65565716891775,['BCKDK'],0.9999902347269571,0,0,1
247,Cytosolic DNA-sensing pathway WP4655,0.5882520179266276,0.9875640087783467,0.5240012862749863,"['POLR1C', 'POLR2E', 'POLR2K', 'POLR2L']",0.9999902347269571,0,0,4
248,Glycogen Synthesis and Degradation WP500,0.5882520179266276,0.9875640087783467,0.5240012862749863,"['PHKG1', 'CALM3', 'GYG2', 'GYG1']",0.9999902347269571,0,0,4
249,VEGFA-VEGFR2 Signaling Pathway WP3888,0.591514859404788,0.9718354718354718,0.5102801684826019,"['NRP2', 'SET', 'TRAF3IP2', 'EPB41', 'RPL10A', 'APOLD1', 'FOXO1', 'RPL7', 'HERPUD1', 'ACTG1', 'SCUBE2', 'LDHA', 'RPS6KA5', 'RPL18A', 'TMSB4X', 'RPLP2', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'ATP6V1E1', 'CCT7', 'HRAS', 'SSR4', 'TRPC3', 'PRKCD', 'RPS6', 'FN1', 'GAB1', 'RPL13A', 'RAB11A', 'CYCS', 'RPL27', 'PRKD1', 'RPL26', 'CALR', 'EIF3D', 'EIF4G2', 'ARF6']",0.9999902347269571,0,0,39
250,Interleukin-11 Signaling Pathway WP2332,0.6119166597282139,0.9556127144441561,0.46935795976342265,"['TGFB1', 'RPS6', 'HRAS', 'RUNX2']",0.9999902347269571,0,0,4
251,Alpha 6 Beta 4 signaling pathway WP244,0.6125633153449003,0.9660564454614798,0.4734671330253274,"['PRKCD', 'GAB1', 'HRAS']",0.9999902347269571,0,0,3
252,Complement system WP2806,0.6125633153449003,0.9660564454614798,0.4734671330253274,"['RPS19', 'CD59', 'CALR']",0.9999902347269571,0,0,3
253,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.613012964019924,0.9494312422570109,0.464622402528749,"['SFRP4', 'SFRP1', 'PORCN', 'TCF7', 'CXXC4']",0.9999902347269571,0,0,5
254,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.613012964019924,0.9494312422570109,0.464622402528749,"['IFI27L2', 'MAPK11', 'PRKCH', 'PRKCD', 'HRAS']",0.9999902347269571,0,0,5
255,Amino Acid metabolism WP3925,0.6173254074939898,0.942415355905092,0.4545825205157738,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'SRM']",0.9999902347269571,0,0,7
256,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6174572228052966,0.987582176771366,0.4761582902522478,"['TICAM2', 'PLAT']",0.9999902347269571,0,0,2
257,Purine metabolism and related disorders WP4224,0.6174572228052966,0.987582176771366,0.4761582902522478,"['PRPS1', 'APRT']",0.9999902347269571,0,0,2
258,Pathways Regulating Hippo Signaling WP4540,0.6199393166729655,0.9402228976697061,0.44955223602664046,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'KIT', 'FGFR3', 'CDH18']",0.9999902347269571,0,0,8
259,Melanoma WP4685,0.633612257844183,0.9255494505494506,0.4223449596263195,"['GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'GADD45G']",0.9999902347269571,0,0,6
260,IL-6 signaling pathway WP364,0.6347207254290831,0.9256583760058522,0.42077669395597406,"['PRKCD', 'GAB1', 'VIP', 'AGT']",0.9999902347269571,0,0,4
261,Metabolic reprogramming in colon cancer WP4290,0.6347207254290831,0.9256583760058522,0.42077669395597406,"['LDHA', 'PKM', 'MDH2', 'PGAM1']",0.9999902347269571,0,0,4
262,Metapathway biotransformation Phase I and II WP702,0.6360827097473121,0.9254402054292002,0.41869383720516906,"['NNMT', 'GPX4', 'GSS', 'CYP51A1', 'KCNAB1', 'SULT4A1', 'CYP3A5', 'FMO5']",0.9999902347269571,0,0,8
263,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.6370315403288289,1.0581856100104274,0.477174103456946,['ELOB'],0.9999902347269571,0,0,1
264,ID signaling pathway WP53,0.6370315403288289,1.0581856100104274,0.477174103456946,['ID2'],0.9999902347269571,0,0,1
265,Leptin and adiponectin WP3934,0.6370315403288289,1.0581856100104274,0.477174103456946,['LEPR'],0.9999902347269571,0,0,1
266,Mitochondrial CII Assembly WP4920,0.6370315403288289,1.0581856100104274,0.477174103456946,['SDHAF1'],0.9999902347269571,0,0,1
267,Serotonin and anxiety-related events WP3944,0.6370315403288289,1.0581856100104274,0.477174103456946,['CRH'],0.9999902347269571,0,0,1
268,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6370315403288289,1.0581856100104274,0.477174103456946,['TGFB1'],0.9999902347269571,0,0,1
269,BDNF-TrkB Signaling WP3676,0.6387730560119494,0.9257127192982456,0.41491003449922703,"['TRPC3', 'GAB1', 'HRAS']",0.9999902347269571,0,0,3
270,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6387730560119494,0.9257127192982456,0.41491003449922703,"['PRKCH', 'PRKCD', 'HRAS']",0.9999902347269571,0,0,3
271,miRNA regulation of prostate cancer signaling pathways WP3981,0.6387730560119494,0.9257127192982456,0.41491003449922703,"['CDKN1B', 'TCF7', 'FOXO1']",0.9999902347269571,0,0,3
272,1q21.1 copy number variation syndrome WP4905,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['FMO5', 'TJP2']",0.9999902347269571,0,0,2
273,Fluoropyrimidine Activity WP1601,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['DPYD', 'GGH']",0.9999902347269571,0,0,2
274,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['RPS6', 'FOXO1']",0.9999902347269571,0,0,2
275,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['LDHA', 'RPS6']",0.9999902347269571,0,0,2
276,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['GOT1', 'MDH2']",0.9999902347269571,0,0,2
277,Trans-sulfuration and one-carbon metabolism WP2525,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['AHCY', 'GSS']",0.9999902347269571,0,0,2
278,Tryptophan metabolism WP465,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['DHCR24', 'ACMSD']",0.9999902347269571,0,0,2
279,White fat cell differentiation WP4149,0.6491896536103596,0.9257669831994156,0.39995946210426053,"['DDIT3', 'FOXO1']",0.9999902347269571,0,0,2
280,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6517322973664808,0.9065709800403678,0.388122426504435,"['PSMD8', 'PSMC5', 'TUBB2A', 'HSPA5', 'UBE2L6', 'STUB1']",0.9999902347269571,0,0,6
281,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.653207394663415,0.9029389708245545,0.38452612942019965,"['CDKN1B', 'TMSB4X', 'FN1', 'MYLK', 'PFN2']",0.9999902347269571,0,0,5
282,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.653207394663415,0.9029389708245545,0.38452612942019965,"['CDKN1B', 'INF2', 'TGFB1', 'FAT1', 'VIM']",0.9999902347269571,0,0,5
283,PI3K-Akt signaling pathway WP4172,0.6552595161493645,0.930352628077179,0.39328230429898325,"['CDKN1B', 'ANGPT2', 'HGF', 'RPS6', 'F2R', 'ITGA1', 'FN1', 'VEGFB', 'IGF1', 'FGF1', 'GHR', 'RELN', 'FGF9', 'IL7', 'GNG4', 'DDIT4', 'PDGFC', 'KIT', 'COL6A6', 'HRAS', 'FGFR3']",0.9999902347269571,0,0,21
284,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6566381751423744,0.8975194520183547,0.37751654808287755,"['TGFBR3', 'TGFB1', 'HRAS', 'RUNX2']",0.9999902347269571,0,0,4
285,Tumor suppressor activity of SMARCB1 WP4204,0.6637120357240326,0.8885964912280702,0.36424183725641657,"['H3F3B', 'ACTL6A', 'GLI3']",0.9999902347269571,0,0,3
286,DNA Repair Pathways Full Network WP4946,0.668608966141958,0.9045343137254902,0.36412562000565163,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'RPA3', 'POLE2', 'APEX1', 'POLE3', 'USP1', 'FAAP100']",0.9999902347269571,0,0,11
287,Head and Neck Squamous Cell Carcinoma WP4674,0.6692925115612042,0.8883516483516484,0.35670345952933064,"['RPS6', 'DDIT4', 'GAB1', 'FAT1', 'HRAS', 'FGFR3']",0.9999902347269571,0,0,6
288,Glucocorticoid Receptor Pathway WP2880,0.6776516025578585,0.8710357588536511,0.3389391623129894,"['TGFBR3', 'RGS2', 'B3GNT5', 'MFGE8']",0.9999902347269571,0,0,4
289,Angiogenesis WP1539,0.6787917281116854,0.8712241653418124,0.3375479023768255,"['TIMP2', 'TIMP3']",0.9999902347269571,0,0,2
290,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6787917281116854,0.8712241653418124,0.3375479023768255,"['NDUFA13', 'AAMP']",0.9999902347269571,0,0,2
291,15q11.2 copy number variation syndrome WP4940,0.6802359234015896,0.9258211678832117,0.35673333398605794,['TUBGCP4'],0.9999902347269571,0,0,1
292,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6802359234015896,0.9258211678832117,0.35673333398605794,['GABBR1'],0.9999902347269571,0,0,1
293,Hypertrophy Model WP516,0.6802359234015896,0.9258211678832117,0.35673333398605794,['WDR1'],0.9999902347269571,0,0,1
294,miRNAs involved in DNA damage response WP1545,0.6802359234015896,0.9258211678832117,0.35673333398605794,['CDKN1B'],0.9999902347269571,0,0,1
295,Non-homologous end joining WP438,0.6802359234015896,0.9258211678832117,0.35673333398605794,['DCLRE1C'],0.9999902347269571,0,0,1
296,RAS and bradykinin pathways in COVID-19 WP4969,0.6802359234015896,0.9258211678832117,0.35673333398605794,['AGT'],0.9999902347269571,0,0,1
297,TCA cycle in senescence WP5050,0.6802359234015896,0.9258211678832117,0.35673333398605794,['GOT1'],0.9999902347269571,0,0,1
298,ATM Signaling Network in Development and Disease  WP3878,0.6977513871694239,0.8460654195840736,0.30449253006915106,"['DCLRE1C', 'KAT5', 'HMGN1', 'CDK5R1']",0.9999902347269571,0,0,4
299,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6977513871694239,0.8460654195840736,0.30449253006915106,"['TGFB1', 'ICMT', 'TCF7', 'RUNX2']",0.9999902347269571,0,0,4
300,Retinoblastoma gene in cancer WP2446,0.702684040686199,0.8540152155536771,0.3013375030978575,"['ANLN', 'CDKN1B', 'H2AFZ', 'RPA3', 'POLE2', 'MCM6']",0.9999902347269571,0,0,6
301,T-cell receptor (TCR) signaling pathway WP69,0.702684040686199,0.8540152155536771,0.3013375030978575,"['TGFB1', 'PRKCD', 'PTK2B', 'CD247', 'VIM', 'HRAS']",0.9999902347269571,0,0,6
302,Endothelin Pathways WP2197,0.7063209135235955,0.8227416605794984,0.28605542217162083,"['ADCY10', 'MYLK']",0.9999902347269571,0,0,2
303,Genes controlling nephrogenesis WP4823,0.7063209135235955,0.8227416605794984,0.28605542217162083,"['ETV4', 'GLI3']",0.9999902347269571,0,0,2
304,NRF2-ARE regulation WP4357,0.7063209135235955,0.8227416605794984,0.28605542217162083,"['AIMP2', 'SLC7A11']",0.9999902347269571,0,0,2
305,Physiological and pathological hypertrophy of the heart WP1528,0.7063209135235955,0.8227416605794984,0.28605542217162083,"['MAPK11', 'AGT']",0.9999902347269571,0,0,2
306,Gastrin signaling pathway WP4659,0.7085600258166166,0.8648664111219178,0.29796420929713036,"['PRKCH', 'CDKN1B', 'KAT5', 'RPS6', 'PRKCD', 'KIT', 'PRKD1', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,9
307,Copper homeostasis WP3286,0.7097646313302689,0.8226120857699805,0.282009412767675,"['COX17', 'FOXO1', 'ATOX1']",0.9999902347269571,0,0,3
308,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7097646313302689,0.8226120857699805,0.282009412767675,"['IFITM3', 'MAPK11', 'DDIT3']",0.9999902347269571,0,0,3
309,IL-2 signaling pathway WP49,0.7097646313302689,0.8226120857699805,0.282009412767675,"['RPS6', 'PTK2B', 'HRAS']",0.9999902347269571,0,0,3
310,G Protein Signaling Pathways WP35,0.7107218784285662,0.857954001722543,0.29296906653499366,"['PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PDE1A', 'PRKCD', 'PRKD1', 'HRAS']",0.9999902347269571,0,0,8
311,Glioblastoma signaling pathways WP2261,0.7138963755323193,0.8492139800971107,0.2861999381297252,"['CDKN1B', 'PRKCH', 'PRKCD', 'GAB1', 'SPRY2', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,7
312,Circadian rhythm related genes WP3594,0.7166396711345095,0.8775464321846546,0.2923827766566694,"['AHCY', 'BHLHE41', 'RBM4B', 'AHR', 'HCRTR2', 'CIART', 'PER2', 'HTR7', 'DBP', 'ID2', 'CRH', 'PTGDS', 'ATF5', 'RPS27A']",0.9999902347269571,0,0,14
313,Insulin Signaling WP481,0.7166396711345095,0.8775464321846546,0.2923827766566694,"['XBP1', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'FOXO1', 'LIPE', 'MAPK11', 'RPS6KA5', 'GYG1', 'HRAS', 'PFKM', 'SH2B2', 'ARF6']",0.9999902347269571,0,0,14
314,Nucleotide Excision Repair WP4753,0.7169348655889113,0.8224823213850281,0.27369767689055163,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.9999902347269571,0,0,4
315,Regulation of Microtubule Cytoskeleton WP2038,0.7169348655889113,0.8224823213850281,0.27369767689055163,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2']",0.9999902347269571,0,0,4
316,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.7183009401978333,0.8228710462287104,0.27226059548396975,['RUNX2'],0.9999902347269571,0,0,1
317,Canonical and non-canonical TGF-B signaling WP3874,0.7183009401978333,0.8228710462287104,0.27226059548396975,['TGFB1'],0.9999902347269571,0,0,1
318,Fatty acid transporters WP5061,0.7183009401978333,0.8228710462287104,0.27226059548396975,['FABP3'],0.9999902347269571,0,0,1
319,Ganglio Sphingolipid Metabolism WP1423,0.7183009401978333,0.8228710462287104,0.27226059548396975,['B3GALT1'],0.9999902347269571,0,0,1
320,Hedgehog Signaling Pathway Netpath WP47,0.7183009401978333,0.8228710462287104,0.27226059548396975,['GLI3'],0.9999902347269571,0,0,1
321,"NAD metabolism, sirtuins and aging WP3630",0.7183009401978333,0.8228710462287104,0.27226059548396975,['FOXO1'],0.9999902347269571,0,0,1
322,RalA downstream regulated genes WP2290,0.7183009401978333,0.8228710462287104,0.27226059548396975,['HRAS'],0.9999902347269571,0,0,1
323,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7308998525115883,0.7931547619047619,0.2486372262044805,"['MAP1LC3A', 'IGFBP5', 'IGF1']",0.9999902347269571,0,0,3
324,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7352055308549919,0.8001739852507957,0.24613766679985255,"['ADCY10', 'TGFB1', 'BANF1', 'HRAS']",0.9999902347269571,0,0,4
325,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7352055308549919,0.8001739852507957,0.24613766679985255,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'RPS6']",0.9999902347269571,0,0,4
326,MECP2 and Associated Rett Syndrome WP3584,0.7483514470114315,0.8071928071928072,0.2339911193050254,"['SST', 'GAD1', 'RPS6', 'OPRK1', 'IGF1', 'FKBP5']",0.9999902347269571,0,0,6
327,BMP Signaling Pathway in Eyelid Development WP3927,0.7518375486089324,0.7405109489051095,0.21121964358793668,['SFRP1'],0.9999902347269571,0,0,1
328,FOXA2 pathway WP5066,0.7518375486089324,0.7405109489051095,0.21121964358793668,['FOXO1'],0.9999902347269571,0,0,1
329,Leptin Insulin Overlap WP3935,0.7518375486089324,0.7405109489051095,0.21121964358793668,['LEPR'],0.9999902347269571,0,0,1
330,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.7518375486089324,0.7405109489051095,0.21121964358793668,['SOX4'],0.9999902347269571,0,0,1
331,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7518375486089324,0.7405109489051095,0.21121964358793668,['BCL2L2'],0.9999902347269571,0,0,1
332,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7518375486089324,0.7405109489051095,0.21121964358793668,['SFRP4'],0.9999902347269571,0,0,1
333,Riboflavin and CoQ disorders WP5037,0.7518375486089324,0.7405109489051095,0.21121964358793668,['RFK'],0.9999902347269571,0,0,1
334,Serotonin and anxiety WP3947,0.7518375486089324,0.7405109489051095,0.21121964358793668,['CRH'],0.9999902347269571,0,0,1
335,Tryptophan catabolism leading to NAD+ production WP4210,0.7518375486089324,0.7405109489051095,0.21121964358793668,['KMO'],0.9999902347269571,0,0,1
336,MTHFR deficiency WP4288,0.7554681053201175,0.7403214024835646,0.20759923591052995,"['CHDH', 'CYCS']",0.9999902347269571,0,0,2
337,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7690486349317197,0.7589893646952901,0.1993114170802983,"['DCLRE1C', 'KAT5', 'ACTL6A', 'BAX']",0.9999902347269571,0,0,4
338,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7716984260592166,0.7707265739385066,0.1997426126762851,"['SFRP4', 'SFRP1', 'PORCN', 'TCF7', 'CXXC4']",0.9999902347269571,0,0,5
339,Ebola Virus Pathway on Host WP4217,0.7745510858084489,0.7995875552735421,0.20427196131930953,"['ITGA1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'MFGE8', 'ASGR1', 'ACTG1']",0.9999902347269571,0,0,8
340,Neovascularisation processes WP4331,0.7772653785875935,0.7049984347281645,0.1776408838549536,"['TGFB1', 'KIT']",0.9999902347269571,0,0,2
341,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7772653785875935,0.7049984347281645,0.1776408838549536,"['TGFB1', 'BAX']",0.9999902347269571,0,0,2
342,Sphingolipid pathway WP1422,0.7772653785875935,0.7049984347281645,0.1776408838549536,"['CERS4', 'SERINC1']",0.9999902347269571,0,0,2
343,GDNF/RET signaling axis WP4830,0.7813841238109634,0.6731254147312542,0.1660522411100672,['GLI3'],0.9999902347269571,0,0,1
344,Omega-3/Omega-6 FA synthesis WP4723,0.7813841238109634,0.6731254147312542,0.1660522411100672,['ACOT2'],0.9999902347269571,0,0,1
345,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7813841238109634,0.6731254147312542,0.1660522411100672,['LDHA'],0.9999902347269571,0,0,1
346,Regulation of Actin Cytoskeleton WP51,0.7831946429916905,0.8132720588235294,0.19874256862039402,"['FGF9', 'CFL2', 'TMSB4X', 'CHRM5', 'F2R', 'ITGA1', 'FN1', 'FGF1', 'FGFR3', 'MYLK', 'ACTG1']",0.9999902347269571,0,0,11
347,Kit receptor signaling pathway WP304,0.7846521807088548,0.7399414776883687,0.17944671603064444,"['RPS6', 'KIT', 'HRAS', 'SH2B2']",0.9999902347269571,0,0,4
348,Small cell lung cancer WP4658,0.7887131936368699,0.7652140962485791,0.18162550203034056,"['CDKN1B', 'GADD45A', 'FN1', 'CYCS', 'BAX', 'GADD45G']",0.9999902347269571,0,0,6
349,Lipid Metabolism Pathway WP3965,0.7973413709839224,0.6728866458596189,0.15239023475145425,"['LIPE', 'PRKAR1A']",0.9999902347269571,0,0,2
350,Leptin signaling pathway WP2034,0.8010127304240764,0.7521698640342708,0.16689027520182204,"['CFL2', 'RPS6', 'LEPR', 'BAX', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,6
351,Pathways in clear cell renal cell carcinoma WP4018,0.8010127304240764,0.7521698640342708,0.16689027520182204,"['LDHA', 'PKM', 'TGFB1', 'BHLHE41', 'ALDOC', 'PFKM']",0.9999902347269571,0,0,6
352,Apoptosis Modulation by HSP70 WP384,0.8074150757713412,0.6169708029197081,0.13198078925875717,['CYCS'],0.9999902347269571,0,0,1
353,Globo Sphingolipid Metabolism WP1424,0.8074150757713412,0.6169708029197081,0.13198078925875717,['B3GALNT1'],0.9999902347269571,0,0,1
354,Heart Development WP1591,0.8074150757713412,0.6169708029197081,0.13198078925875717,['VEGFB'],0.9999902347269571,0,0,1
355,Cell cycle WP179,0.8148589300500503,0.7501593777891113,0.15358783556691202,"['TGFB1', 'CDKN1B', 'GADD45A', 'MCM6', 'CDC14B', 'ANAPC11', 'GADD45G']",0.9999902347269571,0,0,7
356,Melatonin metabolism and effects WP3298,0.8157968369569095,0.6435671864579032,0.13102379801315653,"['PER2', 'FOXO1']",0.9999902347269571,0,0,2
357,Focal Adhesion WP306,0.82097014002075,0.7938387760318407,0.15659941669723612,"['SHC3', 'HGF', 'ITGA1', 'FN1', 'VEGFB', 'TESK2', 'IGF1', 'MYLK', 'ACTG1', 'RELN', 'PDGFC', 'COL5A2', 'HRAS']",0.9999902347269571,0,0,13
358,Male infertility WP4673,0.8239372783729628,0.7273644388398487,0.14086203035954656,"['ABCB1', 'MSH4', 'PEX10', 'AHR', 'TEX15', 'ETV5']",0.9999902347269571,0,0,6
359,Non-small cell lung cancer WP4255,0.8240116722640043,0.7111583511656718,0.13765933721226897,"['GADD45A', 'CYCS', 'BAX', 'HRAS', 'GADD45G']",0.9999902347269571,0,0,5
360,DNA damage response (only ATM dependent) WP710,0.825272619741123,0.7393695014662757,0.14198962742258067,"['TGFB1', 'CDKN1B', 'TCF7', 'BAX', 'HRAS', 'LDLR', 'BBC3']",0.9999902347269571,0,0,7
361,Integrated breast cancer pathway WP1984,0.8285703637045153,0.7741596638655462,0.14558344726789363,"['GADD45A', 'ODC1', 'BAX', 'AHR', 'PHB', 'HMGCR', 'FAU', 'JAKMIP1', 'BACH1', 'RPP38', 'FOXO1']",0.9999902347269571,0,0,11
362,Transcription co-factors SKI and SKIL protein partners WP4533,0.8303484439619339,0.569455362156092,0.10586736340057389,['SATB2'],0.9999902347269571,0,0,1
363,Transcription factor regulation in adipogenesis WP3599,0.8303484439619339,0.569455362156092,0.10586736340057389,['FOXO1'],0.9999902347269571,0,0,1
364,PPAR signaling pathway WP3942,0.8331172776555517,0.6527992776057792,0.1191886516996507,"['FABP3', 'SCD', 'SLC27A6']",0.9999902347269571,0,0,3
365,Pathways affected in adenoid cystic carcinoma WP3651,0.8387952315295746,0.6724080601183747,0.1182017151173986,"['MYCBP', 'CNTN6', 'HRAS', 'FOXP2']",0.9999902347269571,0,0,4
366,Rett syndrome causing genes WP4312,0.8387952315295746,0.6724080601183747,0.1182017151173986,"['SATB2', 'IMPDH2', 'HAP1', 'GABRD']",0.9999902347269571,0,0,4
367,Prion disease pathway WP3995,0.8482496883097447,0.5919649379108839,0.09742573319199072,"['HSPA5', 'RFX5']",0.9999902347269571,0,0,2
368,Canonical and non-canonical Notch signaling WP3845,0.8505525912546833,0.5287278415015642,0.08558466461838013,['CNTN6'],0.9999902347269571,0,0,1
369,Hematopoietic Stem Cell Differentiation WP2849,0.8505525912546833,0.5287278415015642,0.08558466461838013,['RUNX1'],0.9999902347269571,0,0,1
370,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.8505525912546833,0.5287278415015642,0.08558466461838013,['MYLK'],0.9999902347269571,0,0,1
371,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8505525912546833,0.5287278415015642,0.08558466461838013,['MAPK11'],0.9999902347269571,0,0,1
372,Toll-like Receptor Signaling related to MyD88 WP3858,0.8505525912546833,0.5287278415015642,0.08558466461838013,['TICAM2'],0.9999902347269571,0,0,1
373,Immune response to tuberculosis WP4197,0.8683521031709851,0.49343065693430654,0.06965168356650725,['IFIT3'],0.9999902347269571,0,0,1
374,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8703391055847393,0.5996917970602181,0.0832806191737943,"['MAP1LC3A', 'GTPBP2', 'FTL']",0.9999902347269571,0,0,3
375,Hepatitis B infection WP4666,0.8706355229017977,0.7149353417649567,0.09904131403415103,"['MAPK11', 'TICAM2', 'TGFB1', 'ATP6AP1', 'VDAC3', 'CYCS', 'PTK2B', 'BAX', 'HRAS']",0.9999902347269571,0,0,9
376,AMP-activated protein kinase (AMPK) signaling WP1403,0.8714840192001607,0.62930162337157,0.0865653162066705,"['LIPE', 'STRADB', 'LEPR', 'HMGCR']",0.9999902347269571,0,0,4
377,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8714840192001607,0.62930162337157,0.0865653162066705,"['SGCD', 'ITGA1', 'TCF7', 'ACTG1']",0.9999902347269571,0,0,4
378,22q11.2 copy number variation syndrome WP4657,0.872090981957618,0.6719280719280719,0.0919610995450354,"['RANBP1', 'MRPL40', 'RELN', 'THAP7', 'RCC1', 'RAN']",0.9999902347269571,0,0,6
379,DNA IR-damage and cellular response via ATR WP4016,0.8752824328724302,0.6484549587732141,0.08637981890475396,"['FANCI', 'SEM1', 'POLN', 'ABRAXAS1', 'USP1']",0.9999902347269571,0,0,5
380,CAMKK2  Pathway WP4874,0.8754130396960116,0.5480074669263858,0.07291757687772009,"['FIS1', 'MAP1LC3A']",0.9999902347269571,0,0,2
381,Hedgehog Signaling Pathway WP4249,0.8754130396960116,0.5480074669263858,0.07291757687772009,"['HHIP', 'GLI3']",0.9999902347269571,0,0,2
382,IL-5 signaling pathway WP127,0.8754130396960116,0.5480074669263858,0.07291757687772009,"['SPRED1', 'RPS6']",0.9999902347269571,0,0,2
383,Type 2 papillary renal cell carcinoma WP4241,0.8754130396960116,0.5480074669263858,0.07291757687772009,"['TGFB1', 'ELOB']",0.9999902347269571,0,0,2
384,mRNA Processing WP411,0.8794644812320629,0.7252691701680672,0.09315509586363338,"['SF3B5', 'LSM7', 'SF3A1', 'CPSF1', 'SNRPD1', 'NCBP2', 'CD2BP2', 'SNRPE', 'SNU13', 'SNRPA1', 'SRSF9']",0.9999902347269571,0,0,11
385,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8840329874088844,0.4625456204379562,0.0570137899136716,['H3F3B'],0.9999902347269571,0,0,1
386,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8840329874088844,0.4625456204379562,0.0570137899136716,['HRAS'],0.9999902347269571,0,0,1
387,NAD+ biosynthetic pathways WP3645,0.8840329874088844,0.4625456204379562,0.0570137899136716,['ACMSD'],0.9999902347269571,0,0,1
388,Oxidative Stress WP408,0.8840329874088844,0.4625456204379562,0.0570137899136716,['TXN2'],0.9999902347269571,0,0,1
389,Amyotrophic lateral sclerosis (ALS) WP2447,0.8872450359751501,0.5283835959511635,0.06321268661172227,"['TOMM40', 'BAX']",0.9999902347269571,0,0,2
390,16p11.2 distal deletion syndrome WP4950,0.8978472556451178,0.43529411764705883,0.046905256542423585,['CD81'],0.9999902347269571,0,0,1
391,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8978472556451178,0.43529411764705883,0.046905256542423585,['MAP1LC3A'],0.9999902347269571,0,0,1
392,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8978472556451178,0.43529411764705883,0.046905256542423585,['FOXO1'],0.9999902347269571,0,0,1
393,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8978472556451178,0.43529411764705883,0.046905256542423585,['HRAS'],0.9999902347269571,0,0,1
394,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8978472556451178,0.43529411764705883,0.046905256542423585,['MDH2'],0.9999902347269571,0,0,1
395,Vitamin D in inflammatory diseases WP4482,0.8978472556451178,0.43529411764705883,0.046905256542423585,['DUSP1'],0.9999902347269571,0,0,1
396,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8980274296679088,0.5101130953880255,0.05486504352487744,"['CYCS', 'ACTG1']",0.9999902347269571,0,0,2
397,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8980274296679088,0.5101130953880255,0.05486504352487744,"['TGFB1', 'IFIT2']",0.9999902347269571,0,0,2
398,Vitamin D-sensitive calcium signaling in depression WP4698,0.8980274296679088,0.5101130953880255,0.05486504352487744,"['GPX4', 'PVALB']",0.9999902347269571,0,0,2
399,MET in type 1 papillary renal cell carcinoma WP4205,0.898290337258499,0.5913679590343819,0.06343127897659578,"['HGF', 'RPL11', 'GAB1', 'HRAS']",0.9999902347269571,0,0,4
400,Thermogenesis WP4321,0.89942919410828,0.6545528787260106,0.06937929679550081,"['LIPE', 'ADCY10', 'MAPK11', 'RPS6', 'ACTL6A', 'HRAS', 'ACTG1']",0.9999902347269571,0,0,7
401,Wnt signaling pathway and pluripotency WP399,0.8994931227151857,0.6158491947291361,0.06523313084020124,"['PRKCH', 'PRKCD', 'TCF7', 'PRKD1', 'LDLR']",0.9999902347269571,0,0,5
402,Endoderm differentiation WP2853,0.9038706203276005,0.6638363820719332,0.0670933111233561,"['DUSP4', 'SFRP1', 'TGFB1', 'TCEAL2', 'TCF7', 'SLC2A12', 'PBX3', 'FOXO1']",0.9999902347269571,0,0,8
403,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9057243957370081,0.6463068181818182,0.06399744214940986,"['MAPK11', 'NRP2', 'TGFB1', 'ID2', 'FN1', 'STRAP', 'HRAS']",0.9999902347269571,0,0,7
404,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9060625400226431,0.5797151340419123,0.05718712787044509,"['CDKN1B', 'APEX1', 'RPS6', 'HRAS']",0.9999902347269571,0,0,4
405,B Cell Receptor Signaling Pathway WP23,0.9066031717337121,0.6056933010104889,0.059388495873584655,"['CD81', 'PRKCD', 'GAB1', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,5
406,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9078422964035016,0.49306062819576335,0.047671368548028746,"['PDE3A', 'CYCS']",0.9999902347269571,0,0,2
407,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9078422964035016,0.49306062819576335,0.047671368548028746,"['MAPK11', 'BAX']",0.9999902347269571,0,0,2
408,Cardiac Hypertrophic Response WP2795,0.9084668744411765,0.5409713307659393,0.05193154565515409,"['TGFB1', 'PRKD1', 'IGF1']",0.9999902347269571,0,0,3
409,Hippo-Merlin Signaling Dysregulation WP4541,0.9087138197704084,0.6242996440179539,0.05976112344713661,"['PRKAR1A', 'ITGA1', 'KIT', 'FGFR3', 'HRAS', 'CDH18']",0.9999902347269571,0,0,6
410,TGF-beta Signaling Pathway WP366,0.9096341576558553,0.6563952066519931,0.06216901798996659,"['TGFBR3', 'TGFB1', 'PARD6A', 'SUMO1', 'FN1', 'STRAP', 'NEDD9', 'RUNX2']",0.9999902347269571,0,0,8
411,Fatty Acid Biosynthesis WP357,0.9100169621611792,0.4110705596107056,0.038760681611569696,['SCD'],0.9999902347269571,0,0,1
412,Gastric Cancer Network 2 WP2363,0.9100169621611792,0.4110705596107056,0.038760681611569696,['FANCI'],0.9999902347269571,0,0,1
413,Glycerolipids and Glycerophospholipids WP4722,0.9100169621611792,0.4110705596107056,0.038760681611569696,['CDIPT'],0.9999902347269571,0,0,1
414,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9100169621611792,0.4110705596107056,0.038760681611569696,['TRPC3'],0.9999902347269571,0,0,1
415,7q11.23 copy number variation syndrome WP4932,0.9148382174557719,0.6155677655677656,0.05479048083182446,"['ATP5MC2', 'EIF4H', 'ATP5MC3', 'UBE2L6', 'ATP5F1E', 'ATP5MC1']",0.9999902347269571,0,0,6
416,AGE/RAGE pathway WP2324,0.9162570661762129,0.5280388471177945,0.046181387163238136,"['PRKCD', 'CYCS', 'FOXO1']",0.9999902347269571,0,0,3
417,IL-3 signaling pathway WP286,0.9167670524376748,0.4771083201771955,0.041461605805382884,"['TGFB1', 'HRAS']",0.9999902347269571,0,0,2
418,Prader-Willi and Angelman Syndrome WP3998,0.9167670524376748,0.4771083201771955,0.041461605805382884,"['NDN', 'GABRD']",0.9999902347269571,0,0,2
419,Wnt signaling WP428,0.919514449339033,0.5863487415463989,0.0492002418764848,"['SFRP4', 'SFRP1', 'PORCN', 'TCF7', 'CXXC4']",0.9999902347269571,0,0,5
420,Sphingolipid Metabolism (general overview) WP4725,0.9207377622174506,0.3893968497887053,0.0321563976372011,['CERS4'],0.9999902347269571,0,0,1
421,Nanoparticle triggered autophagic cell death WP2509,0.9301820490051252,0.3698905109489051,0.02677081107237534,['MAP1LC3A'],0.9999902347269571,0,0,1
422,Sphingolipid Metabolism (integrated pathway) WP4726,0.9301820490051252,0.3698905109489051,0.02677081107237534,['CERS4'],0.9999902347269571,0,0,1
423,Pancreatic adenocarcinoma pathway WP4263,0.9308223798780731,0.5681946165108683,0.04073205618765756,"['TGFB1', 'GADD45A', 'PRKCD', 'BAX', 'GADD45G']",0.9999902347269571,0,0,5
424,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9310676000468594,0.6529555961584728,0.046636304935641776,"['LINGO1', 'RAB3A', 'RPS6KA5', 'SHC3', 'RPS6', 'PRKCD', 'PTK2B', 'HRAS', 'SH2B2', 'CDK5R1']",0.9999902347269571,0,0,10
425,Alzheimer's disease WP2059,0.932127667459466,0.5373412249783867,0.037767292060577606,"['ATP5MD', 'CYCS', 'CALM3', 'CDK5R1']",0.9999902347269571,0,0,4
426,3q29 copy number variation syndrome WP4906,0.9361347955082231,0.4926900584795322,0.03251547484628181,"['TGFB1', 'NCBP2', 'DYNLL2']",0.9999902347269571,0,0,3
427,Neural Crest Differentiation WP2064,0.9361347955082231,0.4926900584795322,0.03251547484628181,"['HDAC10', 'ASCL1', 'FGFR3']",0.9999902347269571,0,0,3
428,16p11.2 proximal deletion syndrome WP4949,0.9375281717061396,0.5276935938969589,0.03404070730467688,"['ASPHD1', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9999902347269571,0,0,4
429,Pathogenic Escherichia coli infection WP2272,0.9389043367696933,0.43488162248098655,0.02741566927317291,"['TUBB2A', 'ACTG1']",0.9999902347269571,0,0,2
430,ESC Pluripotency Pathways WP3931,0.9406903056130104,0.5511243198356679,0.0336964604409895,"['FGF9', 'GAB1', 'FGF1', 'FGFR3', 'HRAS']",0.9999902347269571,0,0,5
431,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.942535164420135,0.5183844761868094,0.030679056313615005,"['SLCO1C1', 'RPS6', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,4
432,IL17 signaling pathway WP2112,0.9458305990405561,0.3361977438619774,0.018723456417960766,['TRAF3IP2'],0.9999902347269571,0,0,1
433,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9468610755837416,0.4716312056737589,0.025752429695768297,"['GHR', 'MAPK11', 'F2R']",0.9999902347269571,0,0,3
434,Splicing factor NOVA regulated synaptic proteins WP4148,0.9504218275699533,0.41064037009982957,0.02088080161873548,"['EPB41', 'APLP2']",0.9999902347269571,0,0,2
435,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9514660121945757,0.5007129307031356,0.024911125799060338,"['TGFB1', 'IGF1', 'AGT', 'MYLK']",0.9999902347269571,0,0,4
436,Signal transduction through IL1R WP4496,0.9522866105689979,0.321548714693748,0.01572026841890175,['TGFB1'],0.9999902347269571,0,0,1
437,Histone Modifications WP2369,0.9553725008377327,0.3995024973841628,0.018238871562486738,"['SET', 'H3F3B']",0.9999902347269571,0,0,2
438,IL-4 signaling pathway WP395,0.9553725008377327,0.3995024973841628,0.018238871562486738,"['MAPK11', 'HRH1']",0.9999902347269571,0,0,2
439,ErbB signaling pathway WP673,0.9567117831479571,0.5198688470500897,0.023005808035679122,"['CDKN1B', 'SHC3', 'GAB1', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,5
440,Glycerophospholipid Biosynthetic Pathway WP2533,0.9579736433290078,0.30812043795620436,0.013229155185585817,['CDIPT'],0.9999902347269571,0,0,1
441,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9579736433290078,0.30812043795620436,0.013229155185585817,['RPS6'],0.9999902347269571,0,0,1
442,Fatty acid beta-oxidation WP143,0.9629832315113163,0.29576642335766423,0.011156096565752947,['LIPE'],0.9999902347269571,0,0,1
443,Intraflagellar transport proteins binding to dynein WP4532,0.9629832315113163,0.29576642335766423,0.011156096565752947,['DYNLL2'],0.9999902347269571,0,0,1
444,PDGFR-beta pathway WP3972,0.9629832315113163,0.29576642335766423,0.011156096565752947,['HRAS'],0.9999902347269571,0,0,1
445,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9638909805612921,0.37894027083216275,0.013936317212992213,"['MAPK11', 'RPS6KA5']",0.9999902347269571,0,0,2
446,EGF/EGFR signaling pathway WP437,0.9651052848810308,0.5943803180773151,0.02111124774189301,"['NDUFA13', 'RPS6KA5', 'PRKCD', 'GAB1', 'PTK2B', 'SPRY2', 'NEDD8', 'HRAS', 'FOXO1', 'ARF6']",0.9999902347269571,0,0,10
447,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9665993873734031,0.543448062972681,0.018461557494089776,"['DLX2', 'VIPR2', 'PRKAR1A', 'SST', 'ATP1A3', 'TAC1', 'ASCL1']",0.9999902347269571,0,0,7
448,Neural Crest Cell Migration during Development WP4564,0.9673960206000803,0.2843627175743964,0.009425865436790396,['EPHB3'],0.9999902347269571,0,0,1
449,ATM Signaling Pathway WP2516,0.9712830620142912,0.2738037307380373,0.00797791162795373,['GADD45A'],0.9999902347269571,0,0,1
450,Autophagy WP4923,0.9712830620142912,0.2738037307380373,0.00797791162795373,['MAP1LC3B'],0.9999902347269571,0,0,1
451,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9712830620142912,0.2738037307380373,0.00797791162795373,['SUPT4H1'],0.9999902347269571,0,0,1
452,Ectoderm Differentiation WP2858,0.9732309243228574,0.5266547968160872,0.01429019472577048,"['PPFIBP2', 'MAFB', 'HDAC10', 'SPRY2', 'JAKMIP1', 'PTPN13', 'GLI3']",0.9999902347269571,0,0,7
453,Interferon type I signaling pathways WP585,0.9738044500259703,0.35176875717416256,0.009337619166060657,"['RPS6KA5', 'RPS6']",0.9999902347269571,0,0,2
454,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9747069535775827,0.2639989572471324,0.006763234475373535,['TGFB1'],0.9999902347269571,0,0,1
455,Phosphoinositides metabolism WP4971,0.9747069535775827,0.2639989572471324,0.006763234475373535,['PIP4P1'],0.9999902347269571,0,0,1
456,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9769560197744557,0.5160190615835777,0.012030284459830707,"['SLCO1C1', 'MAPK11', 'RPS6KA5', 'SHC3', 'SCD', 'HRAS', 'FOXO1']",0.9999902347269571,0,0,7
457,MAPK Cascade WP422,0.977722844800392,0.25487037503146237,0.005741984589575671,['HRAS'],0.9999902347269571,0,0,1
458,Neural Crest Cell Migration in Cancer WP4565,0.977722844800392,0.25487037503146237,0.005741984589575671,['EPHB3'],0.9999902347269571,0,0,1
459,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9803793225410077,0.24635036496350365,0.004881609457400334,['ACTG1'],0.9999902347269571,0,0,1
460,Netrin-UNC5B signaling pathway WP4747,0.9803793225410077,0.24635036496350365,0.004881609457400334,['PTK2B'],0.9999902347269571,0,0,1
461,Chemokine signaling pathway WP3929,0.9811283955683024,0.4807931199235547,0.009160044388954828,"['SHC3', 'GNG4', 'PRKCD', 'PTK2B', 'CXCL14', 'HRAS']",0.9999902347269571,0,0,6
462,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9827191913517367,0.2383800329644455,0.004155408457367175,['GABRD'],0.9999902347269571,0,0,1
463,Ras signaling WP4223,0.9833518617615076,0.5302202643171806,0.008901484151176546,"['HTR7', 'SHC3', 'GNG4', 'KIT', 'GAB1', 'CALM3', 'FGFR3', 'HRAS', 'ARF6']",0.9999902347269571,0,0,9
464,MAPK Signaling Pathway WP382,0.9836877964184217,0.5795956620698889,0.009532443125506879,"['DUSP4', 'TGFB1', 'GADD45A', 'DUSP1', 'PRKCD', 'FGF1', 'DUSP7', 'MAPK11', 'RPS6KA5', 'FGF9', 'DDIT3', 'HRAS', 'FGFR3']",0.9999902347269571,0,0,13
465,G13 Signaling Pathway WP524,0.984780161262899,0.23090784671532846,0.0035413988368689984,['CFL2'],0.9999902347269571,0,0,1
466,Toll-like Receptor Signaling Pathway WP75,0.9863527279070532,0.30761504747991236,0.0042270159288011954,"['MAPK11', 'TICAM2']",0.9999902347269571,0,0,2
467,PDGF Pathway WP2526,0.9881943354569561,0.21728209531987977,0.002580421472183544,['HRAS'],0.9999902347269571,0,0,1
468,Corticotropin-releasing hormone signaling pathway WP2355,0.9886715662546924,0.3512949039264829,0.004002334179951642,"['TGFB1', 'PRKCD', 'CRH']",0.9999902347269571,0,0,3
469,TNF-alpha signaling pathway WP231,0.9897522507864491,0.3457716557017544,0.00356166205268763,"['RFK', 'BAX', 'HRAS']",0.9999902347269571,0,0,3
470,Common Pathways Underlying Drug Addiction WP2636,0.9908429274241862,0.20517031630170315,0.0018874143210925662,['ACTG1'],0.9999902347269571,0,0,1
471,RANKL/RANK signaling pathway WP2018,0.991935359041186,0.1996054448609193,0.0016162723698949014,['PAPSS2'],0.9999902347269571,0,0,1
472,Regulation of toll-like receptor signaling pathway WP1449,0.9924303398156186,0.33019114951558,0.0025089427454375764,"['MAPK11', 'TICAM2', 'PELI3']",0.9999902347269571,0,0,3
473,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9928975096415256,0.19433346139070304,0.00138517648090722,['MAPK11'],0.9999902347269571,0,0,1
474,Prolactin Signaling Pathway WP2037,0.993711773199372,0.26827810611594394,0.0016923200169939611,"['RPS6', 'HRAS']",0.9999902347269571,0,0,2
475,Integrin-mediated Cell Adhesion WP185,0.9949690050070092,0.3114652829256239,0.0015709352845098648,"['SHC3', 'ITGA1', 'HRAS']",0.9999902347269571,0,0,3
476,Energy Metabolism WP1541,0.9951485168004834,0.18006053053231263,0.0008756865498231655,['FOXO1'],0.9999902347269571,0,0,1
477,Ciliary landscape WP4352,0.9957466669976606,0.5035635446231472,0.0021463913444268777,"['PSMD8', 'DOCK5', 'CD2BP2', 'HTRA2', 'COPS7A', 'MYL6B', 'MCM6', 'VIM', 'COX6C', 'DCAF11', 'DYNLL2', 'LSM4']",0.9999902347269571,0,0,12
478,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9962372018156913,0.1716516720420981,0.0006471088348234645,['HRAS'],0.9999902347269571,0,0,1
479,Mesodermal commitment pathway WP2857,0.9962692869945269,0.3386222031632318,0.001265664643784593,"['PRKAR1A', 'SLC2A12', 'PBX3', 'RPL38']",0.9999902347269571,0,0,4
480,Fragile X Syndrome  WP4549,0.998325139654108,0.3405116316902554,0.0005707875574969173,"['PRKAR1A', 'GAD1', 'GAB1', 'SLC6A1', 'GABRD']",0.9999902347269571,0,0,5
481,Ciliopathies WP4803,0.9987982891895454,0.3780673193030878,0.0004546007887679182,"['MAK', 'NME9', 'HYDIN', 'CCDC65', 'CCNQ', 'CCDC28B', 'GLI3']",0.9999902347269571,0,0,7
482,Joubert Syndrome WP4656,0.9997684578778887,0.11330713082537901,2.6238411287603023e-05,['KAT5'],0.9999902347269571,0,0,1
483,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999902347269571,0.07897339298328232,7.712005111008252e-07,['TULP3'],0.9999902347269571,0,0,1
